Philippines - English - FDA (Food And Drug Administration)

le jumont pharmaceuticals, inc. - paracetamol - suspension (oral drops) - 100 mg/ml

European Union - English - EMA (European Medicines Agency)

h. lundbeck a/s - nalmefene hydrochloride dihydrate - alcohol-related disorders - drugs used in alcohol dependence - selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking-risk level (see section 5.1), without physical withdrawal symptoms and who do not require immediate detoxification.selincro should only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption.selincro should be initiated only in patients who continue to have a high drinking-risk level two weeks after initial assessment.

Austria - English - HMA (Heads of Medicines Agencies)

le vet b.v - benazepril hydrochloride 5 mg - tablet - dogs non food - benazepril

Spain - English - HMA (Heads of Medicines Agencies)

le vet b.v - benazepril hydrochloride 5 mg - tablet - dogs non food - benazepril

France - English - HMA (Heads of Medicines Agencies)

le vet b.v - benazepril hydrochloride 5 mg - tablet - dogs non food - benazepril

Italy - English - HMA (Heads of Medicines Agencies)

le vet b.v - benazepril hydrochloride 5 mg - tablet - dogs non food - benazepril

Netherlands - English - HMA (Heads of Medicines Agencies)

le vet b.v - benazepril hydrochloride 5 mg - tablet - dogs non food - benazepril

Portugal - English - HMA (Heads of Medicines Agencies)

le vet b.v - benazepril hydrochloride 5 mg - tablet - dogs non food - benazepril

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - morphine sulfate (unii: x3p646a2j0) (morphine - unii:76i7g6d29c) - morphine sulfate 15 mg - morphine sulfate extended-release tablets are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. limitations of use morphine sulfate extended-release tablets are contraindicated in patients with: risk summary prolonged use of opioid analgesics during pregnancy may cause neonatal withdrawal syndrome [see warnings and precautions (5.3)] . there are no available data with morphine sulfate extended-release tablets in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. published studies with morphine use during pregnancy have not reported a clear association with morphine and major birth defects [see human data]. in published animal reproduction studies, morphine administered subcutaneously during the early gestational period produced neural tube defects (i.e., exencephaly and cranioschisis) at 5 and 16 times the human daily dose of 60 mg based on body surf

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - miconazole nitrate (unii: vw4h1cyw1k) (miconazole - unii:7nno0d7s5m), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z), petrolatum (unii: 4t6h12bn9u) (petrolatum - unii:4t6h12bn9u) - miconazole nitrate 2.5 mg in 1 g - enter section text here vusion ointment is indicated for the adjunctive treatment of diaper dermatitis only when complicated by documented candidiasis (microscopic evidence of pseudohyphae and/or budding yeast), in immunocompetent pediatric patients 4 weeks and older. a positive fungal culture for candida albicans is not adequate evidence of candidal infection since colonization with c. albicans can result in a positive culture. the presence of candidal infection should be established by microscopic evaluation prior to initiating treatment. vusion should be used as part of a treatment regimen that includes measures directed at the underlying diaper dermatitis, including gentle cleansing of the diaper area and frequent diaper changes. vusion should not be used as a substitute for frequent diaper changes. vusion should not be used to prevent the occurrence of diaper dermatitis, since preventative use may result in the development of drug resistance. the safety and efficacy of vusion have not been d